SAFETY, TOLERABILITY AND PHARMACOKINETIC OF GIC-1001 FOLLOWING MULTIPLE ASCENDING DOSES ADMINISTRATIONS THROUGH AN ADAPTIVE FIRST IN HUMAN STUDY IN HEALTHY VOLUNTEERS.

被引:0
|
作者
Paquette, J. M. [1 ]
Rufiange, M. [1 ]
Sadoune, A. Ait [1 ]
Sicard, E. [1 ]
Massicotte, J. [1 ]
Lefebvre, M. [1 ]
Colin, P. [2 ]
Ranger, M. [2 ]
机构
[1] Algorithme Pharma, Laval, PQ, Canada
[2] gIcare Pharma Inc, Montreal, PQ, Canada
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S61 / S61
页数:1
相关论文
共 50 条
  • [1] A PHASE I ADAPTIVE DESIGN STUDY TO ASSESS SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING ORAL DOSES OF GIC-1001 IN HEALTHY VOLUNTEERS.
    Sayegh, L.
    Rufiange, M.
    Sadoune, A. Ait
    Sicard, E.
    Massicotte, J.
    Lefebvre, M.
    Colin, P.
    Ranger, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S63 - S64
  • [2] Safety, Tolerability and Pharmacokinetics of Trimebutine 3-Thiocarbamoylbenzenesulfonate (GIC-1001) in a Randomized Phase I Integrated Design Study: Single and Multiple Ascending Doses and Effect of Food in Healthy Volunteers
    Paquette, Jean-Michel
    Rufiange, Marianne
    Niculita, Mirela Iovu
    Massicotte, Julie
    Lefebvre, Marc
    Colin, Patrick
    Telmat, Ariles
    Ranger, Maxime
    CLINICAL THERAPEUTICS, 2014, 36 (11) : 1650 - 1664
  • [3] Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers
    Butler, Kathleen
    Teng, Renli
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (01) : 65 - 77
  • [4] Single ascending dose safety, tolerability, and pharmacokinetic study of econazole in healthy volunteers
    Khera, Himanshi
    Pandey, Avaneesh Kumar
    Shafiq, Nusrat
    Khuller, G. K.
    Bhandari, Ritika Kondel
    Panditrao, Aditi
    Gamad, Nanda
    Rohilla, Rachna
    Bhattacharjee, Samiksha
    Murali, Naveen
    Cvn, Harish
    Belavagi, Devraj
    Mothsara, Chakrant
    Singh, Manjula
    Sharma, Navneet
    Behera, Digamber
    Malhotra, Samir
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (06) : 955 - 961
  • [5] A PHASE IB CLINICAL STUDY TO EVALUATE THE ANALGESIC EFFECT OF GIC-1001 AND GIC-1002 ON VISCERAL PAIN UNDER RECTAL DISTENSION USING THE BAROSTAT METHOD IN HEALTHY VOLUNTEERS.
    Paquette, J.
    Niculita, M. Iovu
    Rufiange, M.
    Boily, S.
    Sicard, E.
    Massicotte, J.
    Lefebvre, M.
    Uresandi, O.
    Colin, P.
    Ranger, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S38 - S39
  • [6] SAFETY, TOLERABILITY, PHARMACOKINETICS (PK), AND PHARMACODYNAMICS (PD) OF AZD7594 AFTER SINGLE AND MULTIPLE ASCENDING INHALED DOSES IN HEALTHY MALE VOLUNTEERS.
    Chen, Y.
    Prothon, S.
    Aurivillius, M.
    Eriksson, U. G.
    Aggarwal, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S39 - S39
  • [7] Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers
    Hoover, Randall
    Hunt, Thomas
    Benedict, Michael
    Paulson, Susan K.
    Lawrence, Laura
    Cammarata, Sue
    Sun, Eugene
    CLINICAL THERAPEUTICS, 2016, 38 (01) : 53 - 65
  • [8] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF RG1678, A NOVEL GLYCINE REUPTAKE INHIBITOR: A MULTIPLE ASCENDING DOSE STUDY IN HEALTHY VOLUNTEERS.
    Boetsch, C.
    Hofmann, C.
    Martin-Facklam, M.
    Banken, L.
    Biedinger, U.
    Patat, A.
    Boutouyrie, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S57 - S57
  • [9] Safety, tolerability, and pharmacokinetics of sumatriptan suppositories following single and multiple doses in healthy volunteers
    Kunka, RL
    Hussey, EK
    Shaw, S
    Warner, P
    Aubert, B
    Richard, I
    Fowler, PA
    Pakes, GE
    CEPHALALGIA, 1997, 17 (04) : 532 - 540
  • [10] Pharmacokinetics, Safety, and Tolerability of Rolapitant Administered Intravenously Following Single Ascending and Multiple Ascending Doses in Healthy Subjects
    Wang, Xiaodong
    Zhang, Zhi-Yi
    Wang, Jing
    Powers, Dan
    Arora, Sujata
    Lu, Sharon
    Kansra, Vikram
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (02): : 160 - 171